...
首页> 外文期刊>Pilot and Feasibility Studies >The ACUTE (Ambulance CPAP: Use, Treatment effect and economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure
【24h】

The ACUTE (Ambulance CPAP: Use, Treatment effect and economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure

机译:ACUTE(救护车CPAP:使用,治疗效果和经济性)可行性研究:院前CPAP进行急性呼吸衰竭的先导性随机对照试验

获取原文
           

摘要

Acute respiratory failure (ARF) is a common and life-threatening medical emergency. Standard prehospital management involves controlled oxygen therapy and disease-specific ancillary treatments. Continuous positive airway pressure (CPAP) is a potentially beneficial alternative treatment that could be delivered by emergency medical services. However, it is uncertain whether this treatment could work effectively in United Kingdom National Health Service (NHS) ambulance services and if it represents value for money.MethodsAn individual patient randomised controlled external pilot trial will be conducted comparing prehospital CPAP to standard oxygen therapy for ARF. Adults presenting to ambulance service clinicians will be eligible if they have respiratory distress with peripheral oxygen saturation below British Thoracic Society (BTS) target levels, despite titrated supplemental oxygen. Enrolled patients will be allocated (1:1 simple randomisation) to prehospital CPAP (O_two system) or standard oxygen therapy using identical sealed boxes. Feasibility outcomes will include incidence of recruited eligible patients, number of erroneously recruited patients and proportion of cases adhering to allocation schedule and treatment, followed up at 30?days and with complete data collection. Effectiveness outcomes will comprise survival at 30?days (definitive trial primary end point), endotracheal intubation, admission to critical care, length of hospital stay, visual analogue scale (VAS) dyspnoea score, EQ-5D-5L and health care resource use at 30?days. The cost-effectiveness of CPAP, and of conducting a definitive trial, will be evaluated by updating an existing economic model. The trial aims to recruit 120 patients over 12?months from four regional ambulance hubs within the West Midlands Ambulance Service (WMAS). This sample size will allow estimation of feasibility outcomes with a precision of
机译:急性呼吸衰竭(ARF)是常见且危及生命的医疗紧急情况。标准的院前管理包括控制氧气治疗和针对疾病的辅助治疗。持续的气道正压通气(CPAP)是紧急医疗服务可以提供的潜在有益替代治疗方法。然而,尚不确定这种治疗方法能否在英国国家卫生服务(NHS)救护车服务中有效,并且是否物有所值。方法将进行一项患者随机对照体外试验,将院前CPAP与标准氧疗用于ARF进行比较。尽管有补充氧气的滴定,但仍向有救护车服务的临床医生出诊的成年人,如果其呼吸窘迫的外周血氧饱和度低于英国胸科学会(BTS)的目标水平,则有资格。入组的患者将被分配(采用1:1简单随机分配)进行院前CPAP(O_two系统)或使用相同的密封盒进行标准氧气治疗。可行性结果将包括招募合格患者的发生率,错误招募患者的数量以及遵守分配时间表和治疗的病例比例,在30天后进行随访并收集完整的数据。有效性结果将包括30天生存期(确定的主要试验终点),气管插管,重症监护入院,住院时间,视觉模拟量表(VAS)呼吸困难评分,EQ-5D-5L以及在30天。将通过更新现有的经济模型来评估CPAP的成本效益以及进行确定性试验的成本效益。该试验旨在在12个月内从西米德兰兹地区救护车服务中心(WMAS)的四个地区救护车中心招募120名患者。该样本量将允许以<?5%的精度估算可行性结果。将描述性地报告整个试验人群,每个试验组及其95%置信区间的可行性和有效性结果。讨论这项研究将确定进行CPAP比较的全面试验是否可行,可接受和具有成本效益以及由救护车服务临床医生为ARF提供的标准氧气治疗。这将为NHS实践提供依据,并基于有限的证据和可能的巨大成本防止院前CPAP被不当采用。试用注册ISRCTN12048261。 2017年8月30日注册.http://www.isrctn.com/ISRCTN12048261。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号